Clinical Guest Contributors
-
The Art Of Listening: Strategies For Meaningful Patient Engagement
5/17/2024
Are you truly listening to patients? Discover what it means to be a good listener in the clinical trial setting with The Crohn’s & Colitis Foundation Associate Director of Research Engagement Carol Chapman, MPH.
-
New FDA Draft Guidance: Data Integrity For In Vivo Bioavailability And Bioequivalence Studies
5/16/2024
The FDA's new draft guidance emphasizes maintaining data integrity throughout bioavailability/bioequivalence studies and provides recommendations for applicants and testing site management. The public comment period ends July 3.
-
How Are PIs Paid? All The Options For Clinical Research Investigator Compensation
5/16/2024
Principal investigators' work is much needed and appreciated, but the issue of PI compensation poses challenges for both sites and sponsors. Stamford Health Executive Director of Research Suzanne J. Rose, PhD discusses.
-
Finding The Right Patients For Ketamine Clinical Trials
5/15/2024
Revitalist CEO Kathryn Walker has discusses which patients are well-suited for trials exploring ketamine therapies, especially those for treating mental health conditions.
-
Best Practices For Trial Design And Site Selection In Pediatric Clinical Trials
5/14/2024
“Children are not small adults," reminds Katie Smentek, MD, a PI at Mankato Clinic. Here, Smentek shares her advice for designing trials and selecting sites for pediatric patients.
-
$25 Million Awards Help Cancer Researchers Make Clinical Trial Inroads
5/9/2024
Cancer Grand Challenges — a global research initiative cofounded by Cancer Research U.K. and the National Cancer Institute in the U.S. — supports cancer research that aims to answer some of the field’s most dire questions and pertinent needs.
-
Meaningful Industry Change Means Balancing Tech And Human Touch
5/6/2024
Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
-
Multidisciplinary Collaborations Fuel New Glioma Treatment Breakthroughs
5/6/2024
Servier's Susan Pandya, MD, vice president of clinical development, shares what can be achieved when scientists, patients, investigators, and advocacy groups collaborate to create an innovative trial design for a potential breakthrough therapy.
-
Unleashing The Power Of Investigator-Sponsored Research (ISR) And Investigator-Initiated Trials (IIT)
5/3/2024
Investigator-sponsored research (ISR) and investigator-initiated trials (IIT) are essential to expanding the drugs currently available or under investigation, either alone or in combination, to address unmet medical needs.
-
Early Exposure & Site Network Support Enable PI’s Enduring Interest In Research
4/30/2024
Seasoned Phase 1 principal investigator and site co-director Manish Sharma, MD, recounts his career thus far as a PI, offering insights into PI motivation, retention, and satisfaction.